NS5A sequences of hepatitis C virus genotype 1 and interferon resistance: where are we?
Georgios
G
Germanidis
Simeon
S
Metallidis
Georgia
G
Lazaraki
Jean Michel
JM
Pawlotsky
Paul
P
Nikolaidis
D000595:Amino Acid Sequence; D019943:Amino Acid Substitution; D000998:Antiviral Agents / Q000494:pharmacology*; D024882:Drug Resistance, Viral / Q000235:genetics*; D016174:Hepacivirus / Q000145:classification / Q000235:genetics*; D006526:Hepatitis C / Q000188:drug therapy / Q000821:virology; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000494:pharmacology*; D011092:Polyethylene Glycols / Q000494:pharmacology*; D011994:Recombinant Proteins; D015398:Signal Transduction; D017361:Viral Nonstructural Proteins / Q000235:genetics*; D014779:Virus Replication / Q000187:drug effects; D012324:RNA-Dependent RNA Polymerase
D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011092:Polyethylene Glycols; D011994:Recombinant Proteins; D017361:Viral Nonstructural Proteins; C087036:NS-5 protein, hepatitis C virus; D012324:RNA-Dependent RNA Polymerase; C100416:peginterferon alfa-2a